Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1994; Volume 46,Issue 1
  • You have access
    The gonadotrophin-releasing hormone receptor of alpha T3-1 pituitary cells regulates cellular levels of both of the phosphoinositidase C-linked G proteins, Gq alpha and G11 alpha, equally.
    B H Shah and G Milligan
    Molecular Pharmacology July 1994, 46 (1) 1-7;
  • You have access
    Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
    T M Filtz, Q Li, J L Boyer, R A Nicholas and T K Harden
    Molecular Pharmacology July 1994, 46 (1) 8-14;
  • You have access
    Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
    B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
    Molecular Pharmacology July 1994, 46 (1) 15-23;
  • You have access
    Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking.
    V Sánchez-Margalet, M Valle and R Goberna
    Molecular Pharmacology July 1994, 46 (1) 24-29;
  • You have access
    Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle.
    M T Piascik, M S Smith, E E Soltis and D M Perez
    Molecular Pharmacology July 1994, 46 (1) 30-40;
  • You have access
    Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
    M S Simonson and A Rooney
    Molecular Pharmacology July 1994, 46 (1) 41-50;
  • You have access
    Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
    C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood
    Molecular Pharmacology July 1994, 46 (1) 51-57;
  • You have access
    Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
    M K Ritke, W P Allan, C Fattman, N N Gunduz and J C Yalowich
    Molecular Pharmacology July 1994, 46 (1) 58-66;
  • You have access
    1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
    S Kharbanda, Y Emoto, H Kisaki, A Saleem and D Kufe
    Molecular Pharmacology July 1994, 46 (1) 67-72;
  • You have access
    c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
    N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
    Molecular Pharmacology July 1994, 46 (1) 73-78;
  • You have access
    Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells.
    P M Shaw, M C Weiss and M Adesnik
    Molecular Pharmacology July 1994, 46 (1) 79-87;
  • You have access
    Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases.
    M Chen, C Achkar and L J Gudas
    Molecular Pharmacology July 1994, 46 (1) 88-96;
  • You have access
    Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
    C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
    Molecular Pharmacology July 1994, 46 (1) 97-104;
  • You have access
    Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
    A Christopoulos and F Mitchelson
    Molecular Pharmacology July 1994, 46 (1) 105-114;
  • You have access
    The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
    B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
    Molecular Pharmacology July 1994, 46 (1) 115-121;
  • You have access
    Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708.
    B S Sachais and J E Krause
    Molecular Pharmacology July 1994, 46 (1) 122-128;
  • You have access
    Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
    K M Partin, D K Patneau and M L Mayer
    Molecular Pharmacology July 1994, 46 (1) 129-138;
  • You have access
    Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
    E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri
    Molecular Pharmacology July 1994, 46 (1) 139-145;
  • You have access
    3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons.
    M Park-Chung, F S Wu and D H Farb
    Molecular Pharmacology July 1994, 46 (1) 146-150;
  • You have access
    9-Aminoacridines act at a site different from that for Mg2+ in blockade of the N-methyl-D-aspartate receptor channel.
    M E Nelson and E X Albuquerque
    Molecular Pharmacology July 1994, 46 (1) 151-160;
  • You have access
    Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors.
    K Williams
    Molecular Pharmacology July 1994, 46 (1) 161-168;
  • You have access
    Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel.
    J P Dilger and A M Vidal
    Molecular Pharmacology July 1994, 46 (1) 169-175;
  • You have access
    The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
    K Lee, S E Ozanne, I C Rowe, C N Hales and M L Ashford
    Molecular Pharmacology July 1994, 46 (1) 176-185;
  • You have access
    Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
    P J Hayden, K E Free and C F Chignell
    Molecular Pharmacology July 1994, 46 (1) 186-198;
  • You have access
    Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
    M L Anthony, B C Sweatman, C R Beddell, J C Lindon and J K Nicholson
    Molecular Pharmacology July 1994, 46 (1) 199-211;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 46, Issue 1
1 Jul 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics